Secondary Progressive Multiple Sclerosis (SPMS) - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Secondary Progressive Multiple Sclerosis (SPMS) -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Secondary Progressive Multiple Sclerosis (SPMS) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Secondary Progressive Multiple Sclerosis (SPMS). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Secondary Progressive Multiple Sclerosis (SPMS). The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Secondary Progressive Multiple Sclerosis (SPMS) sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Secondary Progressive Multiple Sclerosis (SPMS) market.

  • Identifying prevalent patient populations as well as risk factors in the global Secondary Progressive Multiple Sclerosis (SPMS) market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Secondary Progressive Multiple Sclerosis (SPMS) therapeutics in each of the markets covered.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Secondary Progressive Multiple Sclerosis (SPMS) - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Secondary Progressive Multiple Sclerosis (SPMS) Overview
Secondary Progressive Multiple Sclerosis (SPMS) Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Secondary Progressive Multiple Sclerosis (SPMS)

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
Sex-Specific Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)
Disease Type Specific Prevalent/Incident Cases of Secondary Progressive Multiple Sclerosis (SPMS)

8.Prevalent & Incident Cases by 7 MM-2015-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of United States-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of United Kingdom-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of Germany-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of France-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of Spain-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of Italy-2025
Secondary Progressive Multiple Sclerosis (SPMS) Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Secondary Progressive Multiple Sclerosis (SPMS) Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Secondary Progressive Multiple Sclerosis (SPMS) Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Secondary Progressive Multiple Sclerosis (SPMS) By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Secondary Progressive Multiple Sclerosis (SPMS) Sub-population,Japan (2015-2025)
  • Multiple Sclerosis -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Multiple Sclerosis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Multiple Sclerosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Multiple Sclerosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated w......
  • Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patt......
  • Global Multiple Sclerosis Drugs Market Professional Survey Report 2017
    Published: 01-Nov-2017        Price: US 3500 Onwards        Pages: 105
    This report studies Multiple Sclerosis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Biogen - Teva Pharmaceutical - Merck KGaA - Novartis ......
  • Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 40
    DelveInsight's, Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Relapsing Multiple Sclerosis (RMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies......
  • EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026
    Published: 01-Nov-2017        Price: US 3995 Onwards        Pages: 35
    EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026 Summary Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed by axon damage and paralysis. MS symptoms include muscle weakness, weak reflexes, tremor, muscle spasm, prolonged double vision, slurred speech, and balance problems. It can occur at any age, but commonly affects people of ages 15-60 years. Women are ab......
  • Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Secondary Progressive Multiple Sclerosis (SPMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the em......
  • Global Multiple Sclerosis Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Multiple Sclerosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Primary Progressive Multiple Sclerosis (PPMS). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Primary Progressive Multiple Sclerosis (PPMS) by development stage, therapy ty......
  • Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Relapsing Multiple Sclerosis (RMS). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Relapsing Multiple Sclerosis (RMS) by development stage, therapy type, route of administration and m......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs